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Cultural Values: Can They Explain
Differences in Health Utilities between
Countries?
Bram Roudijk , A. Rogier T. Donders, and Peep F. M. Stalmeier;
Cultural Values Group
Introduction. Health utilities are widely used in health care. The distributions of utilities differ between countries;
some countries more often report worse than dead health states, while mild states are valued more or less the same.
We hypothesize that cultural values explain these country-related utility differences. Research Question. What is the
effect of sociodemographic background, methodological factors, and cultural values on differences in health utilities?
Methods and Analyses. Time tradeoff data from 28 EQ-5D valuation studies were analyzed, together with their socio-
demographic variables. The dependent variable was Du, the utility difference between mild and severe states.
Country-specific cultural variables were taken from the World Values Survey. Multilevel models were used to analyze
the effect of sociodemographic background, methodology (3L v. 5L), and cultural values on Du. Intraclass correla-
tion (ICC) for country variation was used to assess the impact of the predicting variables on the variation between
countries. Results. Substantial variation in Du was found between countries. Adding cultural values did not reduce
ICCs for country variation. Sociodemographic background variables were only weakly associated with Du and did
not affect the ICC. Du was 0.118 smaller for EQ-5D-5L studies. Discussion. Du varies between countries. These differ-
ences were not explained by national cultural values. In conclusion, despite correction for various variables, utility
differences between countries remain substantial and unexplained. This justifies the use of country-specific value sets
for instruments such as the EQ-5D.
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Health utilities are commonly used in cost-utility analysis
of drugs and interventions in health care.1 They provide
the quality weight in the quality-adjusted life year
(QALY) model and are usually measuring preferences
for hypothetical health states derived from instruments
such as the SF-6D, EQ-5D, or the Health Utility Index
(HUI).2–4 Differences between countries have been
observed in valuations of health utilities by the general
public.5,6 In particular in the EQ-5D valuation system,
for severe health states, the differences between countries
can be as large as 0.4.7 Similarly, differing amounts of
health states considered worse than dead have been
observed, which are health states that are assigned
negative utilities. For example, the 2016 value set for
England has 5% of its health states valued worse than
dead, while the 2017 Indonesian value set has 35% of its
health states valued worse than dead.8,9
Differences between countries persist despite efforts to
harmonize valuation studies. Several sources may con-
tribute to these differences such as the sociodemographic
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backgrounds of the respondents, different valuation
methods, and differing cultural values between countries.
First, sociodemographic factors such as age, sex, educa-
tion, and marital status have been shown to be related to
utilities for health states, albeit weakly.10,11 Also, respon-
dents’ self-reported health and self-description are related
to the valuation of health states.12–14 Second, different
methods of valuation might also affect the outcomes of
valuation studies. There are a variety of methods to value
health states, such as the standard gamble (SG), visual
analog scale (VAS), discrete choice experiments (DCEs),
and, most commonly used, the time tradeoff (TTO).15,16
The results of valuation studies differ systematically by
valuation method.1 Also, a variety of other methodologi-
cal factors affect utilities, such as layouts, indifference
procedures, scale anchors, and transformations of values
for worse than dead health states.17,18 If these factors
explain differences in health state valuations within stud-
ies, they might also explain differences in health state
valuations between countries.
Cultural values have also been hypothesized to explain
differences in utilities between studies.5,6 Cultural values
can be defined as what should be judged as good or evil
by a group.19 Cultural values have been operationalized
by pioneers such as Hofstede and Inglehart.20–22 There is
some evidence that cultural values are related to health;
for instance, the cultural values of Inglehart were shown
to be related to self-reported health.23 Furthermore, it
was shown that utility differences between countries were
related to Hofstede’s cultural values.24 The aim of this
study is to test whether the variation in utilities is caused
by differences in sociodemographic background, metho-
dological factors, or cultural values. Our research ques-
tion is as follows: What is the effect of country,
sociodemographic profile, methodological factors, and
cultural values on differences in health utilities?
Methods
General Approach
We are interested in the determinants of variation in
health utilities between countries, which we aim to
explain by sociodemographic background, methodologi-
cal factors, and cultural values. We focus on differences
between utilities for mild and severe health states for rea-
sons explained in the analyses section.
Valuation Instrument Used in Various Countries
The preference-based valuation instrument that will be
used in this study is the EQ-5D, developed by the
EuroQol Group. This tool assesses utilities for health
states.25 The EQ-5D-3L is a health state classification
system with 3 levels and 5 dimensions that span the
domains of mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression, in that order. On each
of these dimensions, one can have 1) no problems, 2)
some problems, or 3) extreme problems. A score of
11321 on the EQ-5D-3L indicates that a hypothetical
person has no problems with mobility and self-care, has
extreme problems with performing usual activities, some
problems with pain or discomfort, and no problems with
anxiety or depression.
The EQ-5D-5L was developed to improve the sensitiv-
ity of the EQ-5D and to reduce ceiling effects present in
the EQ-5D-3L.26 In addition to the usual 3 levels of
severity, 2 intermediate levels are introduced. One can
now have 1) no problems, 2) slight problems, 3) moderate
problems, 4) severe problems, and 5) extreme problems.
Utility weights are assigned to EQ-5D health states
through valuation studies. The EQ-5D instrument
assigns utility to health states by employing the TTO or
composite TTO (cTTO) methods.27 For states better
than dead, the TTO and cTTO methods allow respon-
dents to choose between 10 years in good health v. 10
years in the health state to be valued. If 10 years in good
health is preferred, the respondent is faced with the
choice between 10 years in the health state or, for exam-
ple, 9 years in good health and so on. The TTO, for
states worse than dead, gives respondents a choice
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between dying immediately or spending x years in the
health state, followed by 10 x years in good health.28
The cTTO, for states worse than dead, gives respondents
a choice between (10 years in good health followed by 10
years in the state worse than dead) and (10 years in good
health). Subsequently, another 10 years of living in good
health can then be traded.27 Utility can then be assigned
to health states using the QALY model, based on the
amount of years traded by the respondents for the given
health states.27
Data Collection
Valuation data were collected from existing EQ-5D
valuation studies. Principal investigators (PIs) of EQ-5D
valuation studies were contacted through email, to ask
for their data. Reminders were sent if the PIs did not
respond after a few weeks, and more reminders were sent
if necessary. PIs were also contacted at 3 EuroQol
Meetings in 2016 and 2017.
Measures
Sociodemographic variables. We selected variables that
were assumed to be related to Du. Age, sex, education,
and EQ-5D self-description were collected from the
valuation data sets. These variables were shown to be
related to utilities in other studies.10,11 If only age classes
were available, the mean of each class was assigned to the
age of the respondent. Educational status was coded as
low, medium, and high. Low education corresponds to at
most finished primary school, middle indicates secondary
education, and high indicates at least some tertiary edu-
cation. Many valuation studies have also collected the
respondent’s own EQ-5D self-description, indicating
whether the respondent had problems on 1 or more
domains of the EQ-5D.
Methodological variables. Methodological variables were
extracted from the research papers of the included valua-
tion studies. We initially considered known methodologi-
cal factors that affect the outcomes of utility assessments
as a basis for the inclusion of methodological variables.18
However, EQ-5D-3L studies were fairly homogeneous,
as the methodology of most 3L studies was derived from
the original Measurement and Valuation of Health
(MVH) study conducted in Britain.3 With the introduc-
tion of the EQ-5D-5L, the methodology of the valuation
studies was standardized, reducing methodological dif-
ferences within the 5L studies.29 A major difference
between 3L and 5L studies is that in 5L studies, the
cTTO was introduced. Hence, a variable representing
whether a study is 3L or 5L was used in our analyses,
which captures, among other differences, whether TTO
or cTTO is used or whether DCE was done complemen-
tary to the cTTO.
Cultural variables. There are several theories on cultural
values, for example, the approach of Hofstede and the
approach of Inglehart.20,22 The approach by Inglehart is
based on the World Values Survey in which large repre-
sentative target samples are obtained. Therefore, we use
their theory to derive national levels of cultural values on
2 dimensions: traditional v. rational/secular values and
survival v. self-expression values.20,21,30 Traditional val-
ues are indicated by a negative score on the traditional/
rational-secular dimension and are related to religion
(importance of God), authority, national pride, lower
levels of tolerance toward homosexuality and abortion,
and stronger family ties, while rational-secular values
imply the opposite and are indicated by a positive score
on the traditional/rational-secular dimension. Survival
values are indicated by a negative score on the survival/
self-expression dimension and are indicated by low levels
of trust, low levels of political activism, and low levels of
tolerance for abortion and homosexuality, while self-
expression values imply the opposite.
Analyses
General Approach
The dependent variable was Du, which represented the
observed TTO utility difference between mild and severe
states. We used Du instead of utilities themselves, as mild
states are valued similarly in most countries, while there
are large country differences between the values assigned
to severe states. In other words, utilities for severe states
are dependent on the country they were measured in,
while utilities for mild states are not. When utilities are
used, interactions are needed in the analysis, such as
country 3 utilities or age 3 countries 3 utilities. This
makes the interpretation of the results difficult and, given
the relatively low number of countries, introduces a risk
of overfitting the model. The proposed method using Du
does not require interactions to be modeled.
Another reason for using Du and not utilities is that
utilities are bounded upward by the value for perfect
health equal to 1, for which our linear models cannot
account. Also, for decision making, at least interval scale
properties are necessary, so the use of differences is natu-
ral. In other words, using Du as the dependent variable
allows us to treat utilities for mild states as an anchor
Roudijk et al. 607
with respect to the utilities for severe states and provides
a feasible method to answer our research question.
Classification of Mild, Moderate, and Severe
States
As we focus on the difference between mild and severe
states, it was necessary to make a classification of which
states are considered mild, moderate, or severe. There is,
to our knowledge, no universal protocol to do so. For
EQ-5D-3L health states, we followed the procedure of
Luo et al.31 Mild states had at most ‘‘moderate prob-
lems’’ or a ‘‘2’’ on 2 domains. Severe states had ‘‘extreme
problems’’ or ‘‘3s’’ on at least 2 of the health domains.
All other health states were considered moderate. For
the EQ-5D-5L, we employed a similar procedure. Mild
states contained at most 2 ‘‘3s’’ (moderate problems on a
maximum of 2 domains), severe states contained at least
two ‘‘5s’’ (extreme problems on at least 2 domains), and
all other states were considered moderate.
Dependent Variable: Utility Differences between
Mild and Severe States
Du was constructed as follows. Each respondent had val-
ued a number of health states, usually around 10, which
may include mild, moderate, and severe states. Each of
these health states was assigned utility by the respondent.
For each respondent, the average utility for the severe
states was subtracted from the average utility for mild
states, which provided an indicator for the difference in
valuation between mild and severe states. For example,
if a respondent had valued 10 states, 3 mild, 4 moderate,
and 3 severe states, only the 3 mild and 3 severe states
were used in our analysis. As health utilities have values
between [–1,1], Du could in principle take any value
between [–2,2] but in practice took values between [0,2].
Respondents who did not value mild and severe states
were excluded, as Du was undefined.
Independent Variables
Dm : correcting for stimulus differences. Health states are
the stimuli presented to respondents in valuation tasks.
The sets of health states differ between countries and
respondents, which made it necessary to control for these
differences. Consequently, Dm was included, based on
what is often called the severity (or misery) index. The
severity index is the sum of the score on the 5 domains
of the EQ-5D. For 3L health states, it ranges from 5 (no
problems on any domain) to 15 (extreme problems on
every domain), while for 5L health states, it ranges from
5 (no problems on any domain) to 25 (extreme problems
on every domain). These were rescaled to a common
severity index that ranged 0, 1½  to analyze both 3L and
5L data. As above, the average severity index for mild
states was subtracted from the average severity index for
severe states to create Dm. Dm can be seen as the average
difference in deviation from full health between mild and
severe states and should be treated as a city-block metric,
which varied at the respondent level.
Sociodemographic, methodological, and cultural variables. Age
was standardized to have a mean of 0 and a standard
deviation of 1, using the overall mean of all included
respondents, while sex was coded as male (0) and female
(1) and education was coded low (1), middle (2), and high
(3). The respondent’s own EQ-5D self-description was
transformed to a single variable and rescaled to [0,1] by
summing up the levels on each dimension, subtracting 5,
and dividing by 10 (in the case of 3L) or 20 (in the case of
5L). For each study, a dummy indicating whether a study
was 3L (0) or 5L (1) was included.
The 2 cultural variables, traditional/rational-secular
and survival/self-expression, ranged between –2 and 2,
and were taken from the World Values Survey. The
World Values Survey currently has data available for 6
study waves, conducted in different time periods. Means
for the 2 cultural dimensions can be calculated by wave.
Cultural data were matched on year of collection of the
EQ-5D data. If this was not possible, the wave that is
closest to the date of collection of the EQ-5D data was
used.
Data Structure and Models
In our analyses, we were interested in Du and whether Du
varied between countries. Furthermore, we were inter-
ested in whether sociodemographic background, metho-
dological factors, and cultural variables could explain
this variation. As respondents were nested in valuation
studies, 2-level mixed-effects models were employed,
which could account for this nested structure. (Some
countries have both a 3L and a 5L data set [e.g., Spain,
the Netherlands, Japan, Singapore, Thailand] for which
different cultural values can be used. Respondents are
nested in studies, which are nested in countries.) The low-
est level was in this case the respondents, while the high-
est level was the study. As EQ-5D valuation studies are
based on nationally representative samples, we assume
that studies represent countries.
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To establish baseline variations of Du for countries,
we started with an empty model, which means that only
the dependent variable and a country-specific intercept
were included in the model. This model is presented in
equation (1).
Duik =b0+ g0k + eik : ð1Þ
Duik represents the utility difference variable for each
respondent i in country k. b0 is the fixed intercept, which
can be interpreted as the average Du across countries. g0k
is the random intercept for country variation for country
k. If g0k is significant, the average Du varies significantly
between countries. eik is the residual variation term at the
respondent level. We assume that g0k is distributed as
g0k ;Nð0,s2g0Þ and that eik is distributed as eik ;Nð0,s2eÞ.
Dm and sociodemographic variables were added sub-
sequently, followed by random slopes for the sociodemo-
graphic variables. These models are presented in
equations (2) to (4):
Duik =b0+ g0k +b1Dmik + eik: ð2Þ
Duik =b0+ g0k +b1Dmik +
X
j
b2jSocdemij+ eik: ð3Þ
Duik =b0+ g0k +b1Dmik +
X
j
(b2j+ g2kj)
Socdemij+ eik: ð4Þ
b1Dmik represents Dm and its coefficient, whileP
j
b2jSocdemij represents the j sociodemographic vari-
ables (age, sex, education, and EQ-5D self-description)
and their respective coefficients. b1 Dmik and b2jSocdemij
are both fixed effects, which means that they can be
interpreted as the average slope across countries for Dm
and the average slope across countries for the sociode-
mographic variables on Du. In other words, these effects
are the same for all countries. In model 4, random slopes
for sociodemographic variables are added. If the
random-effects parameter g2kj is significant, this means
that the slopes of the sociodemographic variables j on
Du vary between countries. We assume that g2kj is dis-
tributed as g2kj;Nð0,s2g2jÞ.
Last, a dummy indicating whether a study is 3L or 5L
was added, followed by the cultural variables. These
models are presented in equations (5) and (6).
Duik =b0+ g0k +b1Dmik +
X
j
(b2j+ g2kj)
Socdemij+b3Fivelevelk + eik: ð5Þ
Duik =b0+ g0k +b1Dmik +
X
j
(b2j+g2kj)
Socdemij+b3Fivelevelk +
X
l
b4lCultkl + eik: ð6Þ
Fivelevelk is the dummy variable indicating that a study
is 3L (0) or 5L (1), with its respective coefficient b3.P
l
b4lCultkl represents both cultural dimensions and their
coefficients (l= 2): b4lCultkl and b3Fivelevelk are fixed
effects and can be interpreted as the average slopes across
countries for these variables on Du.
Assessing Explained Variation between
Countries with Intraclass Correlation
We were interested in the variation of Du between
countries and whether this variation was reduced when
correcting for sociodemographic background, methodo-
logical factors, and cultural values. Intraclass correlation
coefficients (ICCs) are suited to assess the systematic var-
iation between countries and served as the main outcome
variable of this study. The ICC measures the variation
s2g0 in Du between countries relative to the total varia-
tion, the latter being the sum of country variation s2g0
and respondent variation s2e ; see equation (7). For
instance, if the ICC decreased by adding a new variable
while the residual variation remained constant, the varia-
tion between countries was reduced by adding that vari-
able. (Country-level variables cannot affect the residual
variance, which is at the respondent level, since their
value is the same for each respondent within that coun-
try. However, respondent level variables can affect both
the country and the residual variance.) This indicates that
the added variable explains differences between countries.
In general, the ICC can take values between 0 and 1.
ICC=
s2g0
s2g0+s
2
e
for models 1 to 3: ð7Þ
Models 4 to 6 included variation from random slopes for
the sociodemographic variables, while models 1 to 3 did
not. Therefore, the variability of the random slopes y2j
had to be included to calculate the ICC in models 4 to 6,
as shown in equation (8).32 (The ICC for our random
slopes models is defined as
ICC=
s2g0+ SocdemjTSocdemSocdemj
,
+ 2Socdemj

Cov g2j,g0ð Þ+ trace TSocdemSSocdemð Þ
s2
g0
+ SocdemjTSocdemSocdemj
,
+ 2Socdemj

Cov g2j,g0ð Þ+ trace TSocdemSSocdemð Þ+s2e
where Socdemj is the vector of means of each
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sociodemographic variable j that has a random slope
and Socdemj
,
is its transpose. SSocdem is the covariance
matrix of the sociodemographic variables that have ran-
dom slopes, and TSocdem is the covariance matrix of the
random slopes themselves. Since we have standardized
age to have mean zero and unit variance, and age is the
only variable that is included with a random slope, this
expression reduces to equation (8), as TSocdem reduces to
s2g2j and SSocdem reduces to 1, while Socdemj equals 0.) In
equations (7) and (8), s2g0 is the country variation, s
2
g2j is
the variation for sociodemographic variables, and s2e the
residual variation at the respondent level.
ICC=
s2g0 +s
2
g2j
s2
g0
+s2
g2j
+s2e
for models 4 to 6: ð8Þ
Additional analyses included a jackknife analysis to
assess whether a country was considered an influential
point. If a country was influential, associations found for
Du may not be representative for the remainder of the
sample. To detect influential points, the model of equation
(6) was constructed using the original sample, each time
excluding another country from the original sample of
countries. If the ICC was different for the subsample, the
country was considered for exclusion. Furthermore, an
analysis using Hofstede’s cultural dimensions in model 6
was performed to compare the results with those found in
the literature. Last, 4 additional analyses were performed
with stricter or less strict definitions of mild and severe
states to test the robustness of our definition of mild and
severe states. An example of such a definition would be to
define mild 3L states as having at most two 2s, compared
to having at most three 2s in our current definition.
Results
Data Collection and Descriptive Statistics
The collection of data sets started in January 2016 and
ended in August 2017. Forty-four studies were initially
identified as currently completed or ongoing EQ-5D
valuation studies. PIs were contacted through email and
at the EuroQol meetings. Out of these 44 studies, 4 had
not collected TTO data, 3 studies were not published yet,
and 6 PIs were difficult to contact, leaving 31 studies.
One of the data sets could not be shared with us for con-
tractual reasons, leaving 30 studies. Data of 30 studies
were obtained, of which 19 were EQ-5D-3L data sets
and 11 were EQ-5D-5L data sets.9,31,33–59 Two studies
were excluded, as sociodemographic data or cultural val-
ues (in the case of the United Arab Emirates) were not
available. Therefore, 28 studies remained. The jackknife
analysis did not identify any influential points. Thus, 28
countries remained for the final analysis. For 21 of these
studies, information about educational level was also
available, while in 26 of these studies, the EQ-5D self-
description was included.
In total, 690 respondents did not value both mild and
severe states, making it impossible to calculate Du, and
were excluded. Of these exclusions, 592 came from the
Brazilian study, which is a saturation study with a
balanced incomplete block design. Half of the total
amount of respondents in that study did not value at least
1 mild, 1 moderate, and 1 severe state.33 The remaining
98 exclusions came from 12 different studies. In total, the
remaining sample included about 29,140 respondents.
Table 1 provides information on the studies that were
obtained and their characteristics. The scores on the 2
cultural dimensions for each country are shown in Figure
1 and show a wide spread of cultural values. Dotplots
were computed to illustrate the variation in average Du
by country (Figure 2). Du varied by country, as shown in
Figure 2. The smallest Du was about 0.4, which means
that severe states were valued only 0.4 lower than mild
states. The highest Du was around 1.2. Correlations
across countries between Du, age, the cultural variables,
and the 3L or 5L dummy are reported in Table 2.
Multilevel Models
Preliminary analyses that included education and a
rescaled EQ-5D self-description showed that education
was not significant. As 6 studies had no measure of edu-
cation, education was excluded from analysis to avoid
losing data. The EQ-5D self-description was a significant
predictor of Du but could not explain variation in Du
between studies. As 2 studies did not include EQ-5D
self-description, self-description was also excluded from
analysis.
The results from the multilevel analyses are reported
in Table 3. The columns represent the 6 different models
described in equations (1) to (6). The first 7 rows present
the coefficients of the fixed intercept and fixed effects for
the included variable: the bs for the sociodemographic,
methodological, and cultural variables. The next 3 rows
present the random-effect parameters and residual varia-
tion: the sgs and ses. In the last row, the ICC is described.
ICC
In every model, the random intercepts for country varia-
tion were significant, indicated by the row ‘‘RE country’’
in Table 3. This indicated that Du varied reliably between
studies. In the second to last row of Table 3, the ICCs
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show the amount of variation attributed to country dif-
ferences (s2g0) or to residual variation (s
2
e). The empty
model (model 1) has an ICC of 13.1%, indicating that
13.1% of total variation (i.e., variation due to differences
between countries and differences between respondents)
is caused by country differences. Adding Dm and the
sociodemographic variables (models 2–4) yielded a small
reduction in ICC from 13.1% to 12.4%, caused by a
slightly lower variation for the residual and a lower var-
iation for country effects. Adding a random slope for
age increased the ICC from 12.4% to 13.2%, and adding
the 3L/5L dummy (model 5) increased the between-
country variation and the ICC, from 13.2% to 14%.
Adding the cultural variables (model 6) resulted in a fur-
ther increase in ICC from 14% to 14.7%, caused by an
increase in country-level variation. The respondent varia-
tion s2e (Table 3, ‘‘Residual’’) remained stable because
Table 1 Obtained Studies and Their Characteristicsa
Country 3L/5L Year No. of Respondents HS Mode of Administration Elicitation Method
Spain 3L 1997 972 12 Interview TTO
Germany 3L 1997 339 12 Interview TTO
Great Britain 3L 1993 3378 12 Interview TTO
Netherlands 3L 2003 298 17 Interview TTO
Italy 3L 2012 439 17 Interview TTO
Portugal 3L 2012 450 7 Interview TTO
Poland 3L 2008 321 23 Interview TTO
Singapore 3L 2013 455 10 Interview TTO
Japan 3L 1998 543 17 Interview TTO
Taiwan 3L 2007 741 13 Interview TTO
Australia 3L 2011 417 12 Online TTO
France 3L 2008 452 17 Interview TTO
Thailand 3L 2007 1388 10 Interview TTO
Denmark 3L 2000 1332 14 Interview TTO
Brazil 3L 2012 1146 7 Interview TTO
Argentina 3L 2004 611 13 Interview TTO
Zimbabwe 3L 2000 2348 7 Interview TTO
United States 3L 2002 4043 9 Interview TTO
Slovenia 3L 2005 225 13 Interview TTO
Spain 5L 2012 1000 11 Interview cTTO
Canada 5L 2012 1230 10 Interview cTTO
Uruguay 5L 2014 805 13 Interview cTTO
Korea 5L 2013 1080 13 Interview cTTO
Japan 5L 2013 1026 13 Interview cTTO
United Arab Emirates 5L 2013 200 10 Interview cTTO
China 5L 2011 1302 10 Interview cTTO
Netherlands 5L 2012 983 11 Interview cTTO
Singapore 5L 2016 1000 13 Interview cTTO
Thailand 5L 2013 1263 13 Interview cTTO
Indonesia 5L 2015 1054 10 Interview cTTO
cTTO, composite time tradeoff; HS, amount of health states valued by each respondent; TTO, time tradeoff.
a. The mode of administration shows us whether interviewers were present for the TTO or cTTO task, and the elicitation method provides
information on whether TTO or cTTO was used in the study.
Figure 1 Scores on the 2 cultural dimensions, by country.
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respondent variation cannot be affected by adding
country-level variables.
Fixed Effects
The first 7 rows of Table 3 show that in model 3, the
fixed effect of age was only weakly related to Du, while
the fixed effect of sex was not related to Du. In addition,
model 4 shows that the slope for age on Du differed
between studies, shown by ‘‘RE age,’’ the variation in
slope for age. The 3L/5L dummy, indicated by
‘‘Fivelevel’’ in models 5 and 6, was a significant negative
predictor of Du, implying that the utilities for severe
states in 5L studies were raised by 0.118. The fixed
effects for the cultural dimensions of traditional/
rational-secular values and survival/self-expression, indi-
cated by the ‘‘tradrat’’ and ‘‘survself’’ rows in model 6,
were not related to Du.
Additional Analyses
Additional analyses were performed using Hofstede’s
cultural dimensions.22 The same model was used as in
equation (6), now including Hofstede’s 5 cultural dimen-
sions instead of Inglehart’s 2 cultural dimensions. The
results showed that none of the 5 cultural dimensions of
Hofstede was significantly related to Du, and the ICC
decreased slightly by 0.2%.
The analyses with different definitions for mild and
severe states produced similar results. Although the ICC
varied slightly for each model, depending on the defini-
tion of mild and severe states, the same pattern of reduc-
tion in country-level variation was found. The ICC did
not decrease when the Fivelevel dummy was added or
when the cultural variables were added to the models.
Discussion
Main Findings
We aimed to examine the effect of sociodemographic
background, methodological factors, and cultural values
on differences in health utilities, Du, between countries.
We did not find a relation between cultural values and
Du, as neither a linear relation could be found from the
multilevel models, nor did cultural values explain varia-
tion in Du between countries. Dm, the average difference
in severity index between mild and severe states, was
related to Du, as were differences in using a 3L or a 5L
Table 2 Correlations between Average Values per Countrya
Variable 1 Variable 2 Correlation 95% Confidence Interval
Du Tradrat –0.233 –0.563 to 0.161
Du Survself –0.160 –0.509 to 0.235
Du Fivelevel 0.327 –0.060 to 0.629
Du Age –0.119 –0.447 to 0.274
Tradrat Survself 0.233 –0.161 to 0.563
Tradrat Survself 0.099 –0.292 to 0.462
Tradrat Survself 0.353 –0.031 to 0.646
Survself Fivelevel –0.260 –0.582 to 0.133
Survself Age 0.418 0.046 to 0.689b
Fivelevel Age –0.227 –0.559 to 0.168
Survself, survival v. self-expression cultural variable; Tradrat, traditional v. rational-secular cultural variable.
a. One country was excluded, as it was identified as an outlier. Age was standardized before calculating these correlation coefficients.
b. Significant at the 5% level.
Figure 2 Dotplot of average Du scores by country.
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protocol. Sociodemographic variables such as age and
sex were only weakly related to Du. Despite these find-
ings, a large variation between countries remained.
Interpretation
Although cultural values were hypothesized to be related
to variation in utilities for health states, we did not find
a relation between cultural values and Du.5,6 The cultural
variables were not significantly associated with Du,
health utility differences, and they did not decrease varia-
tion in Du between countries. In addition, correlations
between average Du and the 2 cultural variables were
nearly zero. Thus, we conclude that cultural values can-
not account for differences in valuations between coun-
tries. Although we did not find a relation between
cultural values and Du, it was not unreasonable to
hypothesize an association. Findings of previous studies
by Augestad et al.60 and Jakubczyk et al.61 suggested a
possible role for cultural values in explaining differences
in TTO valuations. Jacubczyk et al.61 showed that reli-
gious people assign higher utilities to health states in
TTO valuations. Augestadt et al.60 showed that attitudes
toward euthanasia are related to TTO valuations.
Religion and attitudes toward euthanasia are also related
to our cultural values. For instance, the cultural dimen-
sion ‘‘traditional values’’ is related to a higher impor-
tance of religion. Also, the cultural dimension ‘‘survival
values’’ is related to low tolerance for abortion, which is
likely to be related to ‘‘prolife stances,’’ entailing lower
tolerance for euthanasia. Since both religion and ‘‘prolife
stances’’ seem to be related to Inglehart’s cultural dimen-
sions,23 cultural values are a promising candidate to
explain utility differences between countries.
Our results are contrasted by Bailey and Kind,24 who
looked at the mean TTO value for 7 mild health states in
10 countries, correlated those with 5 Hofstede cultural
dimensions for each country, and found a relation
between Hofstede’s dimensions and the TTO scores.22
The relation found by Bailey and Kind was the strongest
for Hofstede’s ‘‘Power Distance’’ and ‘‘Uncertainty
Avoidance’’ dimensions; these dimensions were also
strongest in our own analysis of Hofstede’s cultural
dimensions. However, there are some differences between
Bailey and Kind’s study24 and our study. Our study
included more countries and considered respondent-level
data, whereas Bailey and Kind24 used mean TTO data
for some specific health states and correlated those with
Hofstede’s cultural dimensions. Furthermore, our study
is on differences in utilities, Du, not on utilities given to
specific health states themselves.
We found 2 predictors of Du. Dm, the average differ-
ence in severity index between mild and severe states, cor-
rects for the selection of health states, whose composition
differed between studies and respondents. As expected,
Dm was related to Du; an increase of 1 in Dm would cause
a 0.978 increase in Du. Furthermore, after correcting for
the selection of health states, differences between 3L and
Table 3 Results from Multilevel Analyses for 27 Countriesa
Variable/Analysis 1 2 3 4 5 6
Constant 0.825b 0.212b 0.202b 0.205b 0.245b 0.253b
Dmi 0.978
b 0.978b 0.974b 0.978b 0.978b
Age 0.0142b 0.004 0.004 0.004
Sex 0.006 0.006 0.006 0.006
Fivelevel –0.118c –0.118c
Tradrat –0.023
Survself –0.011
RE country 0.168b 0.161b 0.160b 0.162b 0.168b 0.173b
RE age 0.037b 0.037b 0.0366b
Residual 0.432b 0.426b 0.427b 0.426b 0.426b 0.426b
ICC, % 13.1 12.5 12.4 13.2 14.0 14.7
Fivelevel is a dummy variable indicating whether 0) 3L or 1) 5L was used. ICC, intraclass correlation; RE, random effect; Survself, survival v.
self-expression cultural variable; Tradrat, traditional v. rational-secular cultural variable.
a. Country-level variables are written in italics. Residual indicates respondent-level variation. Both of these are presented as standard deviations.
The ICC for each model was calculated using Table 2 and equations (7) and (8). For example, in model 1, only a random intercept for country
variation was included. Therefore, the ICC equals ICC=
s2g0
s2
g0
+s2e
= 0:168
2
0:1682 + 0:4322
= 0:131. This indicated that 13.1% of the total variation in Du
could be attributed to differences between countries.
b. Significant at the 1% level.
c. Significant at the 5% level.
Roudijk et al. 613
5L studies remained; that is, Du was smaller for 5L stud-
ies than for 3L studies. This implies that in 5L studies,
values of severe states are raised by 0.118. One possible
explanation could be an upward shift of the values in the
cTTO task, which is used in 5L studies. This shift may
arise for negative states in the cTTO, as the state to be
valued is preceded by 10 years in good health, effectively
changing and improving the state to be valued. Indeed,
Xie et al.62 found that severe states were valued higher in
the cTTO task compared to the TTO task, with average
differences as large as 0.213 for some health states. These
observations corroborate our results.
Limitations and Strengths
This study has some limitations. First, our analyses were
done on existing data, and also, desired data was not col-
lected in all countries. Second, only a small number of
sociodemographic variables could be considered for
analysis, since more could not be analyzed while preser-
ving a sufficient sample of included countries. Third, cul-
tural data were collected at the national level instead of
at the respondent level, which reduces the chance of find-
ing a relation between cultural values and Du. Fourth,
the methods of data collection differ between 3L and 5L
studies. To account for this, we collapsed methodological
differences into a single variable: the 3L/5L dummy.
Fifth, the valuation data were not cleaned, which might
affect our findings, although for preference-based meth-
ods, removing inconsistent responses hardly affects valua-
tions.63,64 Sixth, we assume that EQ-5D valuation studies
use a representative sample for their respective country.
However, since designs and sample sizes differ between
225 and 4043 respondents, we cannot be sure about this,
which is a limitation. Seventh, correlation between the
independent variables made it harder to interpret the
results, which is a limitation of the data. Last, moderate
states were not included in our analyses, so not the whole
spectrum of EQ-5D health states was analyzed.
First, a major strength of this study is its methodol-
ogy; we have combined the largest number of EQ-5D
valuation data sets to date. Second, our method of analy-
sis takes into account the multilevel structure of the data.
Third, our method of analysis is well suited to correct for
disturbing variables. Lastly, the results of our study are
robust as different definitions of mild and severe states
produced similar results.
Practical Implications
Countries use their own EQ-5D tariffs for the calculation
of QALYs in cost-utility analyses. This is reasonable, as
our findings reveal a large amount of variation in Du
between countries. Some protocols aimed to collect
valuation data in many countries with the aim to derive
a common tariff, such as the BIOMED project, which
generated a common VAS value set for European coun-
tries.65 In a similar vein, some countries may rely on
value sets from other countries for the calculation of
QALYs in cost-utility analyses. As we found that utility
differences differ strongly between countries, a multina-
tional tariff or tariffs from a neighboring country would
likely misrepresent the tariff of individual countries. This
strengthens the case for national tariffs for instruments
such as the EQ-5D.
Conclusion
Health utilities differ between countries, as shown, for
example, by the varying amounts of health states worse
than dead reported by EQ-5D valuation studies. The
aim of this article was to assess these differences and to
test whether these differences were related to the sociode-
mographic background of the respondents, methodologi-
cal differences, and cultural values. Cultural values did
not explain Du variation between countries. Despite cor-
rection for various variables, differences in Du between
countries remain substantial.
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